Axogen Inc.

8.68-0.7600-8.05%Vol 157.78K1Y Perf -57.30%
Jun 28th, 2022 16:00 DELAYED
BID8.11 ASK9.08
Open9.42 Previous Close9.44
Pre-Market- After-Market8.84
 - -  0.16 1.84%
Target Price
20.00 
Analyst Rating
Strong Buy 1.00
Potential %
130.42 
Finscreener Ranking
★★★+     51.11
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★     47.55
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★     44.93
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
11.60 
Earnings Rating
Strong Buy
Market Cap364.39M 
Earnings Date
3rd Aug 2022
Alpha-0.00 Standard Deviation0.16
Beta0.71 

Today's Price Range

8.649.43

52W Range

6.8722.47

5 Year PE Ratio Range

-55.10-24.90

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
14.29%
1 Month
-2.88%
3 Months
20.56%
6 Months
1.29%
1 Year
-57.30%
3 Years
-52.32%
5 Years
-38.10%
10 Years
213.62%

TickerPriceChg.Chg.%
AXGN8.68-0.7600-8.05
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
3.70
4.90
0.39
0.65
-24.10
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
81.70
-24.00
-20.40
-21.80
-25.05
RevenueValueIndustryS&P 500US Markets
127.33M
3.03
10.18
21.00
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.23-0.26-13.04
Q04 2021-0.18-0.1233.33
Q03 2021-0.19-0.1615.79
Q02 2021-0.18-0.180.00
Q01 2021-0.20-0.1525.00
Q04 2020-0.16-0.156.25
Q03 2020-0.18-0.0477.78
Q02 2020-0.33-0.2039.39
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.1525.00Positive
9/2022 QR-0.146.67Positive
12/2022 FY-0.668.33Positive
12/2023 FY-0.53-253.33Negative
Next Report Date3rd Aug 2022
Estimated EPS Next Report-0.15
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume157.78K
Shares Outstanding41.98K
Shares Float34.76M
Trades Count2.76K
Dollar Volume1.39M
Avg. Volume317.48K
Avg. Weekly Volume306.11K
Avg. Monthly Volume314.88K
Avg. Quarterly Volume331.45K

Axogen Inc. (NASDAQ: AXGN) stock closed at 9.44 per share at the end of the most recent trading day (a -0.11% change compared to the prior day closing price) with a volume of 265.50K shares and market capitalization of 364.39M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 394 people. Axogen Inc. CEO is Karen Zaderej.

The one-year performance of Axogen Inc. stock is -57.3%, while year-to-date (YTD) performance is 0.75%. AXGN stock has a five-year performance of -38.1%. Its 52-week range is between 6.87 and 22.47, which gives AXGN stock a 52-week price range ratio of 11.60%

Axogen Inc. currently has a PE ratio of -12.60, a price-to-book (PB) ratio of 3.82, a price-to-sale (PS) ratio of 3.11, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -16.55%, a ROC of -17.66% and a ROE of -29.32%. The company’s profit margin is -25.05%, its EBITDA margin is -20.40%, and its revenue ttm is $127.33 Million , which makes it $3.03 revenue per share.

Of the last four earnings reports from Axogen Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. Axogen Inc.’s next earnings report date is 03rd Aug 2022.

The consensus rating of Wall Street analysts for Axogen Inc. is Strong Buy (1), with a target price of $20, which is +130.42% compared to the current price. The earnings rating for Axogen Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Axogen Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Axogen Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.46, ATR14 : 0.64, CCI20 : 42.57, Chaikin Money Flow : -0.06, MACD : 0.03, Money Flow Index : 47.29, ROC : -2.58, RSI : 55.68, STOCH (14,3) : 77.33, STOCH RSI : 0.96, UO : 52.77, Williams %R : -22.67), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Axogen Inc. in the last 12-months were: Alan M. Levine (Option Excercise at a value of $0), Angelo Scopelianos (Option Excercise at a value of $0), Bradley Ottinger (Option Excercise at a value of $0), Eric Sandberg (Option Excercise at a value of $0), Erick Wayne DeVinney (Option Excercise at a value of $36 700), Guido J. Neels (Option Excercise at a value of $0), Isabelle Billet (Option Excercise at a value of $0), Karen Zaderej (Option Excercise at a value of $1 063 174), Karen Zaderej (Sold 41 000 shares of value $757 194 ), Maria D. Martinez (Option Excercise at a value of $0), Mark Louis Friedman (Option Excercise at a value of $0), Mark S. Gold (Option Excercise at a value of $0), Michael Patrick Donovan (Option Excercise at a value of $78 150), Michael Patrick Donovan (Sold 1 935 shares of value $38 777 ), Peter J. Mariani (Option Excercise at a value of $0), Quentin S. Blackford (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
5 (100.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.40

Axogen Inc.

Axogen Inc is a medical technology company. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. The firm's product portfolio includes Avance nerve graft, Axoguard nerve connector and nerve protector, Avive soft tissue membrane, Axotouch two-point membrane, and Acroval Neurosensory and motor testing system.

CEO: Karen Zaderej

Telephone: +1 386 462-6800

Address: 13631 Progress Boulevard, Alachua 32615, FL, US

Number of employees: 394

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

60%40%

Bearish Bullish

59%41%

TipRanks News for AXGN

Thu, 05 May 2022 12:40 GMT Analysts Top Healthcare Picks: AxoGen (AXGN), Protagonist Therapeutics (PTGX)

- TipRanks. All rights reserved.

Thu, 05 May 2022 04:25 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: AxoGen (AXGN), Cytokinetics (CYTK) and Mirati Therapeutics (MRTX)

- TipRanks. All rights reserved.

Thu, 13 Jan 2022 16:51 GMT AxoGen (AXGN) Receives a Buy from JMP Securities

- TipRanks. All rights reserved.

News

Stocktwits